Search research articles
Contact Us
Filters
Showing results (351-360 of 478) with videos related to
Page
of 48
Sort By:
Thrombosis and Haemostasis
|
August 30, 1983
T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates
K Lechner, H Niessner, P Bettelheim, et al.
Blood
|
July 15, 1992
MDR1 RNA expression is an independent prognostic factor in acute myeloid leukemia
R Pirker, J Wallner, M Götzl, et al.
Annals of Hematology
|
August 31, 2000
Culture requirements for induction of dendritic cell differentiation in acute myeloid leukemia
L Oehler, A Berer, M Kollars, et al.
Wiener Klinische Wochenschrift
|
September 29, 2000
Efficacy of standard treatment in patients with Hodgkin's disease--a single center experience
K Geissler, H Gisslinger, P Knöbl, et al.
Advances in Experimental Medicine and Biology
|
September 29, 1999
The lung resistance protein (LRP) predicts poor outcome in acute myeloid leukemia
R Pirker, G Pohl, T Stranzl, et al.
Annals of Hematology
|
July 28, 2001
Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma
N Worel, H Greinix, J Ackermann, et al.
British Journal of Haematology
|
April 1, 1997
Relapse of Philadelphia chromosome positive acute lymphoblastic leukaemia after marrow transplantation: sustained molecular remission after early and dose-escalating infusion of donor leucocytes
F Keil, P Kalhs, O A Haas, et al.
Blood
|
March 1, 1992
In vivo synergism of recombinant human interleukin-3 and recombinant human interleukin-6 on thrombopoiesis in primates
K Geissler, P Valent, P Bettelheim, et al.
Experimental Hematology
|
August 1, 1993
Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4
C Sillaber, D Bevec, J H Butterfield, et al.
Thrombosis and Haemostasis
|
November 3, 1998
Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism
S Eichinger, A Stümpflen, M Hirschl, et al.
Page
of 48
Search research articles
Search
Showing results (351-360 of 478) with videos related to
Sort By:
Page
of 48
Thrombosis and Haemostasis
|
August 30, 1983
T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates
K Lechner, H Niessner, P Bettelheim, et al.
Blood
|
July 15, 1992
MDR1 RNA expression is an independent prognostic factor in acute myeloid leukemia
R Pirker, J Wallner, M Götzl, et al.
Annals of Hematology
|
August 31, 2000
Culture requirements for induction of dendritic cell differentiation in acute myeloid leukemia
L Oehler, A Berer, M Kollars, et al.
Wiener Klinische Wochenschrift
|
September 29, 2000
Efficacy of standard treatment in patients with Hodgkin's disease--a single center experience
K Geissler, H Gisslinger, P Knöbl, et al.
Advances in Experimental Medicine and Biology
|
September 29, 1999
The lung resistance protein (LRP) predicts poor outcome in acute myeloid leukemia
R Pirker, G Pohl, T Stranzl, et al.
Annals of Hematology
|
July 28, 2001
Deletion of chromosome 13q14 detected by fluorescence in situ hybridization has prognostic impact on survival after high-dose therapy in patients with multiple myeloma
N Worel, H Greinix, J Ackermann, et al.
British Journal of Haematology
|
April 1, 1997
Relapse of Philadelphia chromosome positive acute lymphoblastic leukaemia after marrow transplantation: sustained molecular remission after early and dose-escalating infusion of donor leucocytes
F Keil, P Kalhs, O A Haas, et al.
Blood
|
March 1, 1992
In vivo synergism of recombinant human interleukin-3 and recombinant human interleukin-6 on thrombopoiesis in primates
K Geissler, P Valent, P Bettelheim, et al.
Experimental Hematology
|
August 1, 1993
Tumor necrosis factor alpha and interleukin-1 beta mRNA expression in HMC-1 cells: differential regulation of gene product expression by recombinant interleukin-4
C Sillaber, D Bevec, J H Butterfield, et al.
Thrombosis and Haemostasis
|
November 3, 1998
Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism
S Eichinger, A Stümpflen, M Hirschl, et al.
Page
of 48